EU approved biosimilars are interchangeable with reference medicines/ equivalent biosimilar: EMA, HMA Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

Interchangeability in this context means that the reference medicine can be substituted by a biosimilar without a patient experiencing any changes in the clinical effect. EMA’s position is based on the experience gained in clinical practice, where it has become common that doctors switch patients between different biological medicinal products., Interchangeability in this context means that the reference medicine can be substituted by a biosimilar without a patient experiencing any changes in the clinical effect. EMA’s position is based on the experience gained in clinical practice, where it has become common that doctors switch patients between different biological medicinal products., , Read More

Leave a Reply

Your email address will not be published.